| Nov 7 |
Maravai LifeSciences Holdings Non-GAAP EPS of -$0.02 misses by $0.01, revenue of $65.2M misses by $2.53M
|
| Nov 7 |
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
|
| Nov 7 |
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
|
| Oct 15 |
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
|
| Oct 9 |
RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter
|
| Oct 1 |
Codexis licenses Genomics Life Science enzyme portfolio to Alphazyme LLC
|
| Sep 24 |
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
|
| Aug 29 |
Maravai LifeSciences' Cygnus & TriLink Unveil AccuRes DNA Kits
|
| Aug 28 |
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
|
| Aug 16 |
Maravai LifeSciences may be worth $15 to $20 share in a takeout - analyst
|
